World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
31819
World Ranking
12153
National Ranking
164

Overview

Lauren E. Abrey is affiliated with the University of Zurich in Switzerland and has contributed primarily to the field of Medicine, with a focus on several subfields including Genetics, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research, and Molecular Biology.

Their research covers main topics such as:

  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Brain Metastases and Treatment
  • Cancer Genomics and Diagnostics
  • MRI in cancer diagnosis
  • Vascular Malformations Diagnosis and Treatment
  • Statistical Methods in Clinical Trials

Lauren E. Abrey has published in several venues, including:

  • Journal of Clinical Oncology
  • Neuro-Oncology
  • The Lancet Oncology
  • Annals of Clinical and Translational Neurology
  • Neuro-Oncology Advances

The following are recent papers authored by Lauren E. Abrey, including the year of publication and venue:

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma, 2023, Journal of Clinical Oncology
  • Leveraging external data in the design and analysis of clinical trials in neuro-oncology, 2021, The Lancet Oncology
  • Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma, 2020, Annals of Clinical and Translational Neurology
  • Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02, 2020, Neuro-Oncology Advances
  • Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation, 2022, Journal of Neuro-Oncology

Their frequent co-authors include:

  • Timothy F. Cloughesy
  • Patrick Y. Wen
  • Catalina Raymond
  • Josep Garcia
  • Benjamin M. Ellingson

Best Publications

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

    Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen

  • Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

    Olivier L. Chinot;Wolfgang Wick;Warren Mason;Roger Henriksson

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Treatment for Primary CNS Lymphoma: The Next Step

    Lauren E. Abrey;Joachim Yahalom;Lisa M. DeAngelis

  • Long-term survival in primary CNS lymphoma.

    Lauren E. Abrey;Lisa M. DeAngelis;Joachim Yahalom

  • Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    Lauren E. Abrey;Leah Ben-Porat;Katherine S. Panageas;Joachim Yahalom

  • Strategies to advance translational research into brain barriers

    Edward Neuwelt;N Joan Abbott;Lauren Abrey;William A Banks

  • Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Patrick G. Morris;Denise D. Correa;Joachim Yahalom;Jeffrey J. Raizer

  • Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

    Gaurav D. Shah;Joachim Yahalom;Denise D. Correa;Rose K. Lai

  • Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

    Patrick Y. Wen;W. K Alfred Yung;Kathleen R. Lamborn;Patricia L. Dahia

  • Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

    Kathleen R. Lamborn;W. K.Alfred Yung;Susan M. Chang;Patrick Y. Wen

  • Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

    Philip H. Gutin;Philip H. Gutin;Fabio M. Iwamoto;Kathryn Beal;Nimish A. Mohile

  • Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

    F. M. Iwamoto;L. E. Abrey;K. Beal;P. H. Gutin

  • Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma

    Igor T. Gavrilovic;Adília Hormigo;Joachim Yahalom;Lisa M. DeAngelis

  • A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

    Jeffrey J. Raizer;Lauren E. Abrey;Andrew B. Lassman;Susan M. Chang

  • Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma

    James L. Rubenstein;Jane Fridlyand;Lauren Abrey;Arthur Shen

  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

    Antonio Omuro;Denise D. Correa;Lisa M. DeAngelis;Craig H. Moskowitz

  • Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

    Thomas Sandmann;Richard Bourgon;Josep Garcia;Congfen Li

  • Delayed Neurotoxicity in Primary Central Nervous System Lymphoma

    Antonio M. P. Omuro;Leah S. Ben-Porat;Katherine S. Panageas;Amy K. Kim

  • Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

    Roelien H. Enting;Alexis Demopoulos;Lisa M. DeAngelis;Lauren E. Abrey

Frequent Co-Authors

Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center
Michael D. Prados
Michael D. Prados University of California, San Francisco
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Patrick Y. Wen
Patrick Y. Wen Harvard University
Katherine S. Panageas
Katherine S. Panageas Memorial Sloan Kettering Cancer Center
David Schiff
David Schiff University of Virginia
Susan M. Chang
Susan M. Chang University of California, San Francisco
Kathleen R. Lamborn
Kathleen R. Lamborn University of California, San Francisco
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career in the USA, there are several online degree options that can help expand your opportunities—whether you wish to move into advanced nursing, leadership, or specialized roles. For those interested in mental health, the shortest online pmhnp programs offer a fast track to becoming a Psychiatric Mental Health Nurse Practitioner. These online programs allow you to complete your advanced training while balancing work and other commitments.

Aspiring healthcare leaders may want to explore a master’s in administration. There are plenty of cheapest mha programs online that provide an affordable pathway to healthcare management. If you’re seeking even more options, a master’s in healthcare administration online is highly regarded and can lead to roles in hospital administration, consulting, or public health policy.

For those looking to reach the highest level of clinical practice, consider one of the cheapest dnp programs online. Earning your DNP can prepare you for advanced leadership, research, and teaching roles in the evolving healthcare landscape.

Best Scientists Citing Lauren E. Abrey

Trending Scientists